Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
2019
Background: Guidelines caution against the use of non–vitamin K antagonist oral anticoagulants in patients with extremely high (>120 kg) or low (≤60 kg) body weight because of a lack of data in the...
Keywords:
-
Correction
-
Cite
-
Save
0
References
0
Citations
NaN
KQI